Acquired resistance of Escherichia coli to complement lysis by binding of glycophosphoinositol-anchored protectin (CD59)

Infection and Immunity

Volumn 66, Issue 5, 1998, Pages 1928-1933

  Rautemaa, Riina ^a   Jarvis, Gary A ^a,b   Marnila, Pertti ^c   Meri, Seppo ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c FINNISH FOREST RESEARCH INSTITUTE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CD59 ANTIGEN; COMPLEMENT MEMBRANE ATTACK COMPLEX; GLYCOSYLPHOSPHATIDYLINOSITOL; LUCIFERASE; LUCIFERIN; MAGNESIUM ION; POLYSIALIC ACID;

ANTIGEN BINDING; ARTICLE; BACTERIAL COUNT; BACTERIAL MEMBRANE; BACTERIOLYSIS; BIOLUMINESCENCE; COMPLEMENT INHIBITION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; FLOW CYTOMETRY; HOST RESISTANCE; IMMUNOFLUORESCENCE; NONHUMAN; PRIORITY JOURNAL;

EID: 0031925528     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.66.5.1928-1933.1998     Document Type: Article

References (39)

1. Boman, H. G., and D. A. Monner. 1975. Characterization of lipopolysaccharides from Escherichia coli K-12 mutants. J. Bacteriol. 121:455-464.
2. Born, J., and S. Bhakdi. 1986. Does complement kill E. coli by producing transmural pores? Immunology 59:139-145.
3. Brown, E. J., K. A. Joiner, and M. M. Frank. 1983. The role of complement in host resistance to bacteria. Springer Semin. Immunopathol. 6:349-360.
4. Davies, A., D. L. Simmons, G. Hale, R. A. Harrison, H. Tighe, P. J. Lachmann, and H. Waldmann. 1989. CD59, an LY-6-like protein expressed in human lymphoid cells, regulates the action of the complement membrane attack complex on homologous cells. J. Exp. Med. 170:637-654.
5. Fearon, D. T. 1978. Regulation by membrane sialic acid of beta1H-dependent decay-dissociation of amplification C3 convertase of the alternative complement pathway. Proc. Natl. Acad. Sci. USA 75:1971-1975.
6. Heimer, G. V., and C. E. D. Taylor. 1974. Improved mountant for immunofluorescence preparations. J. Clin. Pathol. 27:254-256.
7. Horstmann, R. D., H. J. Sievertsen, J. Knobloch, and V. A. Fischetti. 1988. Antiphagocytic activity of streptococcal M protein: selective binding of complement control protein factor H. Proc. Natl. Acad. Sci. USA 85:1657-1661.
8. Horta, M. F. M., and F. J. Ramalho-Pinto. 1991. Role of human decay-accelerating factor in the evasion of Schistosoma mansoni from the complement-mediated killing in vitro. J. Exp. Med. 174:1399-1406.
9. Joiner, K. A. 1988. Complement evasion by bacteria and parasites. Annu. Rev. Microbiol. 42:201-230.
10. Joiner, K. A., C. H. Hammer, E. J. Brown, R. J. Cole, and M. M. Frank. 1982. Studies on the mechanism of bacterial resistance to complement mediated killing I. J. Exp. Med. 155:797-808.
11. Joiner, K. A., C. H. Hammer, E. J. Brown, and M. M. Frank. 1982. Studies on the mechanism of bacterial resistance to complement mediated killing II. J. Exp. Med. 155:809-919.
12. Joiner, K. A., M. A. Schmelz, M. E. Sanders, T. G. Murray, C. H. Hammer, R. Dourmashkin, and M. M. Frank. 1985. Multimeric complement component C9 is necessary for killing of Escherichia coli J5 by terminal attack complex C5b-9. Proc. Natl. Acad. Sci. USA 82:4808-4812.
13. Jokiranta, T. S., L. Jokipii, and S. Meri. 1995. Complement resistance of parasites. Scand. J. Immunol. 42:9-20.
14. Jones, N. C., and M. J. Osborn. 1977. Interaction of Salmonella typhimurium with phospholipid vesicles, incorporation of exogenous lipids into intact cells. J. Biol. Chem. 252:7398-7404.
15. Kooyman, D. L., G. W. Byrne, S. McClellan, D. Nielsen, M. Tone, H. Waldmann, T. M. Coffman, K. R. McCurry, J. L. Platt, and J. S. Logan. 1995. In vivo transfer of GPI-linked complement restriction factors from erythrocytes to the endothelium. Science 269:89-92.
16. Lampinen, J., L. Koivisto, M. Wahlsten, P. Mäntsälä, and M. Karp. 1992. Expression of luciferase genes from different origins in Bacillus subtilis. Mol. Gen. Genet. 232:498-504.
17. Le Grice, S. F. J., V. Beuck, and J. Mous. 1987. Expression of biologically active human T-cell lymphotropic virus type III reverse transcriptase in Bacillus subtilis. Gene 55:95-103.
18. Lehto, T., and S. Meri. 1993. Interactions of soluble CD59 with terminal complement complexes. J. Immunol. 151:4941-4949.
19. Meri, S., T. Lehto, C. W. Sutton, J. Tyynelä, and M. Baumann. 1996. Structural composition and functional characterization of soluble CD59: heterogeneity of the oligosaccharide and glycophosphoinositol (GPI) anchor revealed by laser-desorption mass spectrometric analysis. Biochem. J. 316:923-935.
20. Meri, S., P. Mattila, and R. Renkonen. 1993. Regulation of CD59 expression on the human endothelial cell line EA.hy 926. Eur. J. Immunol. 23:2511-2516.
21. Meri, S., B. P. Morgan, A. Davies, R. H. Daniels, M. G. Olavesen, H. Waldmann, and P. J. Lachmann. 1990. Human protectin (CD59), an 18.000-20.000 MW complement lysis restricting factor, inhibits C5b-8 catalysed insertion of C9 into lipid bilayers. Immunology 71:1-9.
22. Meri, S., and M. K. Pangburn. 1990. Discrimination between activators and nonactivators of the alternative pathway of complement: regulation via a sialic acid/polyanion binding site on factor H. Proc. Natl. Acad. Sci. USA 87: 3982-3986.
23. Morgan, B. P., and S. Meri. 1994. Membrane proteins that protect against complement lysis. Springer. Semin. Immunopathol. 15:369-396.
24. Pangburn, M. K., and H. J. Müller-Eberhard. 1978. Complement C3 convertase: cell surface restriction of β1H control and generation of restriction on neuraminidase-treated cells. Proc. Natl. Acad. Sci. USA 75:2416-2420.
25. Rautemaa, R., and S. Meri. 1996. Protection of gingival epithelium against complement-mediated damage by strong expression of the membrane attack complex inhibitor protectin (CD59). J. Dent. Res. 75:568-574.
26. 51Cr release from human peripheral blood mononuclear cells pretreated with lipopolysaccharide. Infect. Immun. 55:507-512.
27. Rollins, S. A., and P. J. Sims. 1990. The complement-inhibitory activity of CD59 resides in its capacity to block incorporation of C9 into membrane C5b-9. J. Immunol. 144:3478-3483.
28. Schenkein, H. A. 1988. Failure of Bacteroides gingivalis W83 to accumulate bound C3 following opsonization with serum. J. Periodontal Res. 24:20-27.
29. Schlesinger, L. S., N. R. Bellinger-Kawahara, N. R. Payne, and M. A. Horwitz. 1990. Phagocytosis of Mycobacterium tuberculosis is mediated by human monocytc complement receptors and complement component C3. J. Immunol. 144:2771-2780.
30. Schultz, D. R., and K. D. Miller. 1974. Elastase of Pseudomonas aeruginosa: inactivation of complement components and complement-derived chemotactic and phagocytic factors. Infect. Immun. 10:128-135.
31. Smit, J., Y. Kamio, and H. Nikaido. 1975. Outer membrane of Salmonella typhimurium: chemical analysis and freeze-fracture studies with lipopolysaccharide mutants. J. Bacteriol. 124:942-958.
32. Tomlinson, S., P. W. Taylor, B. P. Morgan, and J. P. Luzio. 1989. Killing of Gram-negative bacteria by complement. Biochem. J. 263:505-511.
33. Vaara, M., P. Viljanen, T. Vaara, and P. H. Mäkelä. 1984. An outer membrane-disorganizing peptide PMBN sensitizes E. coli strains to serum bactericidal action. J. Immunol. 132:2582-2589.
34. Virta, M., M. Karp, S. Rönnemaa, and E.-M. Lilius. 1997. Kinetic measurement of the membranolytic activity of serum complement by using bioluminescent bacteria. J. Immunol. Methods 201:215-221.
35. Virta, M., K. E. O. Åkerman, P. Saviranta, C. Oker-Blom, and M. T. Karp. 1995. Real-time measurement of cell permeabilization with low-molecular-weight membranolytic agents. J. Antimicrob. Chemother. 36:303-315.
36. Vuorio, R., and M. Vaara. 1992. The lipid A biosynthesis mutation lpxA2 of Escherichia coli results in drastic antibiotic supersusceptibility. Antimicrob. Agents Chemother. 36:826-829.
37. Väkevä, A., M. Jauhiainen, C. Ehnholm, T. Lehto, and S. Meri. 1994. High-density lipoproteins can act as carriers of glycophosphoinositol lipid-anchored CD59 in human plasma. Immunology 82:28-33.
38. Väkevä, A., P. Laurila, and S. Meri. 1992. Loss of expression of protectin (CD59) is associated with complement membrane attack complex deposition in myocardial infarction. Lab. Invest. 67:608-616.
39. Wood, K. V., Y. A. Lam, H. H. Seliger, and W. D. McElroy. 1989. Complementary DNA coding click beetle luciferases can elicit bioluminescence of different colors. Science 244:700-702.